港股異動 | 中國宏橋(01378.HK)漲5%創近一年新高 績後獲機構唱好
格隆匯8月25日丨中國宏橋(01378.HK)急升至4.94%創近一年新高,報5.1港元,暫成交1333.7萬港元,最新總市值437.1億港元。中國宏橋8月21日公告,上半年收入較去年同期減少約3.6%,約為399.38億元;公司股東應占淨利潤較去年同期增加約14.3%,約為28.3億元。董事會宣派2020年中期股息每股15.0港仙。興業證券點評稱,公司首次派發中期股息,股息率超過40%,當前估值對應2020E潛在股息率超過9%,穩定的高派息政策有望成為估值修復的催化劑。目標價上調至6.99港元,評級由“增持”調整為“買入”。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.